A long non-coding RNA signature in glioblastoma multiforme predicts survival.
about
Long Non-Coding RNAs: The Key Players in Glioma PathogenesisMolecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNAExploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number dataA long non-coding RNA signature to improve prognosis prediction of colorectal cancer.Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancerA four-long non-coding RNA signature in predicting breast cancer survival.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.A pseudogene-signature in glioma predicts survival.The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.An Association Rule Mining Approach to Discover lncRNAs Expression Patterns in Cancer DatasetsIdentification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.Analysis of SOX2-Regulated Transcriptome in Glioma Stem CellsA potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patientsBiological significance of long non-coding RNA FTX expression in human colorectal cancer.Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer.Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.A long non-coding RNA signature to improve prognosis prediction of gastric cancer.Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinomaA Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types.Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinomaA novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application.The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development.Long noncoding RNAs: a potential novel class of cancer biomarkers.The Dynamics of Interactions Among Immune and Glioblastoma Cells.Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.
P2860
Q26800873-70DB40D9-68D3-4D33-BAF5-B12BB1B4E0E7Q26801277-44365C9B-F7B0-4C26-83D3-3EE1001740D0Q30699293-21AB1A2E-4A68-4182-9547-ECAC758A725DQ33688589-4C027B5B-7FB1-4631-A139-DB23D4BB7A86Q33771364-B1E5536A-80FE-4415-8A41-4E3A40505840Q33775233-BD3B2A34-3E46-40D7-B17F-86502F9E82BAQ34143978-E865C46B-1C72-4B35-9DE3-9B531456731EQ34346056-A56B5F1C-A48B-4F98-B388-16D4BA87032EQ34455481-F98F3A65-B102-4EBC-969E-2D9501848AA5Q35191597-49523F05-A0F1-48EE-A7AC-1A92D442CD57Q35739881-8D77312E-D0E2-4EFA-8A30-42B37E8BD8A4Q35857169-6228ED20-C47B-4DF0-B482-71B1AC9843BAQ35932166-C7A6EBE5-9AE8-4B21-998E-FEBEB284F006Q36053910-EA7A3DF5-B34B-40FB-A689-564F3B27FBF9Q36145048-195F0E53-8414-4689-9773-48CF49F7C420Q36262493-158E8B60-8463-4FFD-A9BE-9A6E132613D6Q36317592-7597B7C4-567A-4330-BC25-986BD403FDD4Q36546750-98858488-E05D-438C-8CC5-7E44B52019C9Q36780620-43EC7D25-4FBD-4510-8D85-C8BEF3CC0916Q37022234-E6E37445-0B91-4105-9AA5-3ABA94935F9FQ37268013-964B10E0-8635-4770-AC62-A0C75E084798Q37301923-B2D1BF3F-F7E7-4F5B-B984-98CCD8B6F463Q37353877-04CFFC0A-85DB-4DB9-8273-CFE71A811145Q37362685-3348788C-7568-408D-819D-1E93F9484F80Q37376448-E246A196-D7D8-44E8-B7A8-C054A6C3E348Q37444484-4F0AA8AD-2203-4E21-8367-E6A72B50F516Q37499268-99D44899-62CC-4D9A-A44D-4EE3E0D78536Q37636634-DC636247-F16A-4816-B594-E4C9D43E4128Q37670401-EB56A341-0967-4DDE-86DE-3C506DF71344Q37705864-621D6D9F-9C02-4EBF-B4D8-C9FBD57B7769Q37716461-4F4D0894-F8A9-4134-AC05-FC9D80F917BEQ38152226-2B618B1E-F07B-47D6-9199-BDCC99144193Q38176848-399F932D-92B9-4B22-9DA0-E0420BFDA510Q38194035-CF8A20A1-6D1F-4899-BFA0-978359214B3EQ38441203-7CBEDDC8-CBDC-4EDD-8777-84D6B437FAC0Q38466810-083527D7-0054-4612-BA15-4AF5E83506A8Q38557236-C148F898-AA87-44AF-A09D-9FDE78032390Q38604550-D43EDBA5-127B-4080-BF25-E70C87E1E2CEQ38758656-FB39AF68-866B-44B3-B672-5305B07EB7F5Q38777383-F3222229-D82E-4892-9DDF-C24CD9836D44
P2860
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@ast
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@en
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@nl
type
label
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@ast
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@en
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@nl
prefLabel
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@ast
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@en
A long non-coding RNA signature in glioblastoma multiforme predicts survival.
@nl
P2093
P50
P1476
A long non-coding RNA signature in glioblastoma multiforme predicts survival
@en
P2093
Amy Shuk-Wai Ho
Ching-Fai Fung
Jenny Kan-Suen Pu
Karrie Mei-Yee Kiang
Stella Sun
Wai-Man Lui
Xiao-Qin Zhang
P304
P356
10.1016/J.NBD.2013.05.011
P577
2013-05-29T00:00:00Z